Randox and Realbio Group signed a strategic authorization agreement. Jointly launching QC product OEM products to provide core raw materials for the domestic production of QC products.

May 26, 2025

DENKA and Realbio Group sign strategic cooperation agreement to jointly establish China International After-Sales Technical Service Center.

March 12, 2025

Shenzhen Fourth People's Hospital (Sami Medical) & Realbio Group signed a strategic cooperation agreement. Realbio has already established research cooperation with more than 100 hospitals in China, forming a sample bank alliance. Internationally, it has established data sharing with European sample banks such as biomex, CBH, and Invent.

October 21, 2024

SEKISUI and Realbio Group signed a strategic cooperation agreement to jointly establish a CRO center in China to conduct R&D, registration, and clinical evaluation.

July 16, 2024

The forum on the "Development of Biological Special Items for Entry and Exit," initiated by the Shenzhen Development and Reform Commission and undertaken by Shanghe innovation Institute, has ushered in a new era for the Shenzhen model of rapid import of biological special items.

December 12, 2023

Sysmex (Wuxi) and Realbio Group signed a strategic cooperation agreement to jointly establish a new product development center.

March 29, 2023

The China Institute of Metrology-Shenzhen Institute of Technological Innovation & Realbio Group signed a strategic cooperation agreement, establishing a partnership with a leading domestic institution in the field of customized quality control.

August 14, 2022

Taiyuan Blood Center & Realbio Group signed a strategic cooperation agreement to jointly establish Shanxi Province's key laboratory for core raw materials of IVD, providing core raw materials for the localization of quality control products.

November 1, 2021

Years of accumulated experience in multi-resistant technology has led to a level of advancement on par with domestic and international standards. Cooperation agreements have been signed with multiple publicly listed companies.
A large quantity of Scantibodies diagnostic serum has been imported from the United States in compliance with regulations.
A strategic cooperation agreement has been signed with the Pingshan District Government to establish the "Shenzhen Pingshan Comprehensive Bonded Zone Bio-Raw Material International R&D and Transformation Center."
Realbio has become one of the first companies to enter the Shenzhen Comprehensive Bonded Zone as part of the "bonded +" innovative industrial project approved by the State Council.
Pre-A round financing is expected to raise 70 million to 100 million RMB.

September 2021

Pingshan District Government & Realbio Group signed a strategic cooperation agreement to establish the Shenzhen Pingshan Comprehensive Bonded Zone Bio-raw Material International R&D and Transformation Center. This center will provide top multinational companies and domestic leading enterprises with a one-stop solution covering R&D, production, registration, after-sales service, warehousing, and import and export.

June 23, 2021

Achieve large-scale compliant import of Biomex diagnostic serum into Germany, becoming a compliant supplier of Biomex domestically;
Achieve large-scale export of animal serum, supplying international listed companies
EPS-G7, APS-5, and acridine ester development completed
The "IVD" core raw material doctoral workstation was unveiled;
Won the first prize in the fourth "China Chuangyi" Entrepreneurship and Innovation Competition selection and the 2020 Yangcheng County Entrepreneurship Competition;

2020

Awarded the Shanxi "Science and Technology Spring" 2018 Annual Private Science and Technology Innovation Enterprise Honor;
Awarded Yangcheng County Reform and Innovation Advanced Collective;
Awarded the Shanxi Province "China Makers" Second Prize;
Awarded the 2019 Jincheng City Innovation and Entrepreneurship Competition First Prize;
Chairman Su Shaobo was selected as a 2018 Shanxi Province "Three Jin Talents";
Chairman Su Shaobo was selected for the Shanxi Province Emerging Industry Leading Talent Honor Certificate;
Accumulated technology related to monoclonal antibodies, invented a method for high-efficiency point transfection of suspension cells;
Accumulated technology related to droplet generation oil development and microfluidics

2019

Realbio Shanxi Provincial Key Laboratory approved;
Awarded Top Ten Private Science and Technology Innovation Enterprises in Shanxi Province;
Awarded Shanxi Province "Four New" Small and Medium-sized Enterprises;
Awarded Yangcheng County Science and Technology Innovation Advanced Collective, Outstanding Contribution Advanced Collective;
Signed a strategic cooperation agreement with Shanxi Provincial Institute of Biology;
Cooperated with Yangcheng County People's Hospital to establish the Chinese Academy of Sciences Yangcheng County Regional Medical Testing Center;
Won the second prize in the 7th China Innovation and Entrepreneurship Competition Shanxi Division;
Obtained the filing of Shanxi Provincial Level II Pathogenic Microorganism Laboratory;
Chairman Mr. Su Shaobo won the 2018 Jincheng City "Innovative Outstanding Youth" honor;
Accumulation of enzyme engineering related technology verification, invention of a glycerol kinase high-density fermentation patent, laboratory expression enzyme activity is higher than similar products on the market;
Mass production of carrier A and carrier B

2018

The Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, and Realbio Group signed a strategic cooperation agreement to jointly establish a CAS joint laboratory, providing customized core raw materials with the brainpower of more than 4,000 researchers.

December 4, 2017

Established the CAS Shenzhen Institute of Advanced Technology Realbio Yang City Biotechnology Joint Laboratory in collaboration with the Chinese Academy of Sciences;
Awarded the Yangcheng County Science and Technology Innovation Advanced Collective;
Passed the ISO9001 quality system certification of the International Organization for Standardization;
Awarded the global Best Newcome certificate by Randox;
Realbio trademark successfully registered, establishing the brand;
Passed the Randox non-medical device risk assessment, achieving the large-scale import of Class B risk products for the first time

September 2017

Realbio-Technology Company was established with a registered capital of 110 million
Shenzhen Realbio Group Co., Ltd. was established
Realbio was awarded the High-Tech Enterprise Certificate;
Chairman Su Shaobo was elected as a standing committee member of the First Committee of the Immunoassay Professional Committee of the Chinese Society for Analytical Testing;
Realbio completed the accumulation of protein purification and multi-antibody immunization related technology verification, and obtained a number of related patents

2016

Obtained export qualification for biological antibodies in Shanxi Province
Establishment of a 40-acre experimental base for immunized animals

2015

Realbio Technology Company was established with a registered capital of 9.21 million yuan, mainly engaged in sheep polyclonal antibodies.

August 2014